This study investigates the effectiveness of different methods to detect Cryptococcal Antigen (CRAG), a substance that indicates a fungal infection called cryptococcosis. The study compares the new CRAG Lateral Flow Assay (LFA) with the standard method known as CRAG Latex Agglutination (LA).
Participants in this study will undergo tests using the CRAG LFA on samples of their cerebrospinal fluid (CSF), serum, and urine. These tests are designed to measure how well the CRAG LFA detects the presence of the Cryptococcal Antigen compared to the traditional LA method.
- Who can participate: No specific eligibility criteria provided.
- Study details: Participants will provide samples of cerebrospinal fluid, serum, and urine for testing. The study will compare the results from the investigational CRAG LFA with the standard LA method. An inactive substance that looks like the investigational medicine/vaccine but does not contain any medicine may be used as a placebo.
